Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.
| Year | ID | Type | Category | Title | Authors |
|---|
| 2021 | MDC11 | Poster | Multidisciplinary Care |
Association between Patient Reported Outcomes and Gait in People with Multiple Sclerosis with Differing Disabilities |
Christina Burke, PT, DPT1,2, Olivia Kaczmarek, BS3, MaryJo Kaleda, PT, DPT1, Elizabeth Casparian, SPT1, James Forbes, SPT1, Jillian Gallindo, SPT1, Morgan Staten, SPT1, Jared Srinivasan, BA3 and Mark Gudesblatt, MD4, (1)Stony Brook University, Stony Brook, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)South Shore Neurologic Associates, Patchogue, NY, (4)South Shore Neurologic Associates, P.C., Islip, NY |
| 2021 | MOC01 | Poster | Methods of Care |
Impact of the COVID-19 Pandemic on People with Multiple Sclerosis: Results from an International Survey |
Alana T Wong, PhD1, Svend S Geertsen, PhD1, Hubert van Hoogstraten, MD, PhD2, Bill Aschenbach, PhD, MBA1 and Jeffrey Chavin, MD, FAAN1, (1)Sanofi, Cambridge, MA, (2)Sanofi, Bridgewater, NJ |
| 2021 | MOC02 | Poster | Methods of Care |
Psychoanalytic Telepsychology with MS Patients and Their Support People |
Gayle R Lewis, Ph.D., MSCS, New York, NY |
| 2021 | MOC03 | Poster | Methods of Care |
Floodlight MS: Using the Jobs-to-be-Done Framework to Identify Unmet Needs in Multiple Sclerosis Care to Support Digital Medical Device Development |
Jorge Cancela, PhD, MBA, Roche, Basel, Switzerland, Cristina Costantino, PhD, Genentech, South San Francisco, CA and Jumaah Goldberg, DPT, Genentech, Inc., South San Francisco, CA |
| 2021 | MOC04 | Poster | Methods of Care |
Floodlight MS: Utilizing Rapid Prototyping and Human Factors Studies to Develop a Digital Medical Device for Patient-Centric MS Care |
Jorge Cancela, PhD, MBA1, Cristina Costantino, PhD2, Jumaah Goldberg, DPT3, Geraint Davies, BSc1 and JP Guyon, MS, MBA4, (1)Roche, Basel, Switzerland, (2)Genentech, South San Francisco, CA, (3)Genentech, Inc., South San Francisco, CA, (4)Roche, Belmont, CA |
| 2021 | MOC05 | Poster | Methods of Care |
Improving Communication Gaps between Physicians Who Treat MS and the Health Insurance Community |
Alexis Crispino, Director of Education & Healthcare Relations (MSAA South-Central), Multiple Sclerosis Association of America, Austin, TX and Kyle E Pinion, Senior Director of Education, Healthcare Relations & Advocacy, Education and Healthcare Relations, Multiple Sclerosis Association of America, Cherry Hill, NJ |
| 2021 | MOC06 | Poster | Methods of Care |
Remote Monitoring in MS – Initial Experience with Medical Device Icompanion |
Lars Costers, PhD1,2, Annabel Descamps, MSc1, Steve De Backer, PhD1, Guy Nagels, MD PhD1,2,3,4, Wim Van Hecke, PhD1 and Dirk Smeets, PhD1,2, (1)icometrix, Leuven, Belgium, (2)AIMS, Vrije Universiteit Brussel (VUB), Brussel, Belgium, (3)Neurology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussel, Belgium, (4)St. Edmund Hall, University of Oxford, Oxford, United Kingdom |
| 2021 | MOC07 | Poster | Methods of Care |
Development and Implementation of a Psychoeducational Model for a Pediatric MS Clinic Transition Program |
Yolanda S Wheeler, PhD, CRNP, CPNP-AC, MSCN, University of Alabama at Birmingham Center for Pediatric Onset Demyelinating Disease, Birmingham, AL; University of Alabama at Birmingham School of Nursing, Birmingham, AL and Evelyn Hunter, PhD, Department of Special Education, Rehabilitation and Counseling, Auburn University, Auburn, AL |
| 2021 | NDM01 | Poster | Neuroimmunology and disease models |
Clinical and Diagnostic Spectrum of Optic Neuritis: A Single-Center Retrospective Study of Disorders Associated with Multiple Sclerosis, Aquaporin-4 Antibody, and Myelin Oligodendrocyte Glycoprotein Antibody |
Dana Siegel, MD, Wayne State University, School of Medicine, detroit, MI, Meredith Van Harn, MPH, Neurology, Henry ford health system, Detroit, MI, Poonam Bansal, MD, Ophthalmology and Neurology, Henry Ford Health System, Detroit, MI, Mirela Cerghet, MD, PhD, Neurology, Henry Ford Hospital, Detroit, MI and Anza B Memon, MD, Neurology, Henry Ford Health System, Detroit, MI; Neurology, Wayne State University, School of Medicine, Detroit, MI |
| 2021 | NDM02 | Poster | Neuroimmunology and disease models |
RGC-32 Contributes to Reactive Astrocytosis in Experimental Autoimmune Encephalomyelitis By Maintaining a Mature Phenotype |
Austin J Beltrand, Medical Student, University of Maryland SOM, Baltimore, MD, Horea Rus, MD, PhD, Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD and Alexandru Tatomir, MD, Neurology, University of Maryland SOM, Baltimore, MD |
| 2021 | NDM03 | Poster | Neuroimmunology and disease models |
Comparing Infection-Related Outcomes By Sex in Patients with Multiple Sclerosis and Matched Controls Using Administrative Claims Data |
Riley Bove, MD1, Terra Slaton, MS2, Chris M. Kozma, PhD2, Amy L. Phillips, PharmD3, Danielle E. Harlow, PhD3 and Carroline Lobo, PhD3, (1)UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, (2)CK Consulting Associates, LLC, West Columbia, SC, (3)EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany |
| 2021 | NDM04 | Poster | Neuroimmunology and disease models |
Effect of Ocrelizumab on Antibody Responses to EBV |
Kaleigh E Olmsted, B.S., McGovern Medical School, Houston, TX and John W Lindsey, MD, Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX |
| 2021 | NDM05 | Poster | Neuroimmunology and disease models |
Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis |
Laura Ghezzi, MD1,2, Claudia Cantoni, PhD3, Daniela Galimberti, PhD2, Elio Scarpini, MD2, Anne Cross, MD1 and Laura Piccio, M.D., Ph.D1,4, (1)Neurology, Washington University in St. Louis, St. Louis, MO, (2)University of Milan, Milan, Italy, (3)Neurology, Washington University in St. Louis, St. louis, MO, (4)Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia |
| 2021 | NDM06 | Poster | Neuroimmunology and disease models |
Phenotype and Functional Characterization of B-Cells, T-Cells and Monocytes Following Alemtuzumab Treatment in Patients with Multiple Sclerosis. |
Nicole Kashani, M.D., Borna Vajdi, M.D., Lauren M Anderson, B.S., Gregory Baltayan, B.S., Eve E Kelland, Ph.D., Wendy Gilmore, Ph.D. and Brett T Lund, Ph.D., Neurology, University of Southern California, Los Angeles, CA |
| 2021 | NDM07 | Poster | Neuroimmunology and disease models |
William Meador, MD, Neurology, UAB, Birmingham, AL and Chander Raman, PhD, Medicine, University of Alabama at Birmingham, Birmingham, AL |
| 2021 | NIB01 | Poster | Non-imaging Biomarkers |
| 2021 | NIB02 | Poster | Non-imaging Biomarkers |
| 2021 | NIB03 | Poster | Non-imaging Biomarkers |
Combinatorial Analysis of Plasma and DNA Methylation Biomarkers in African American Patients with Multiple Sclerosis |
Lindsay Clark, PhD1, Mark Band, PhD2, Jason P. Mendoza, PhD3, Linda Piccinini, PhD3 and Michael D Carrithers, MD, PhD4,5,6, (1)High Performance Biological Computing, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (2)Functional Genomics, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (3)Biogen, Cambridge, MA, (4)Neurology, University of Illinois College of Medicine, CHICAGO, IL, (5)Neurology, Jesse Brown Veterans Hospital, Chicago, IL, (6)Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL |
| 2021 | NIB04 | Poster | Non-imaging Biomarkers |
Predicting Stress Levels and Response to a Self-Management Program Using Participant Demographic, Clinical, and Biomarker Data: A Secondary Analysis |
Nico Osier, PhD, RN1,2, Alexa Stuifbergen, PhD, RN, FAAN1, Sawyer Stubbs, BS3 and Tapasvini Paralkar, BS3, (1)School of Nursing, The University of Texas at Austin, Austin, TX, (2)Neurology, Dell Medical School, Austin, TX, (3)University of Texas at Austin, Austin, TX |
| 2021 | NIB05 | Poster | Non-imaging Biomarkers |
Non-Right-Handedness May be Associated with More Severe Multiple Sclerosis |
Ruth E Propper, Ph.D.1, Melissa Villafana, B.A.1 and Glenn R Wylie, Ph.D.2, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ |
| 2021 | NIB06 | Poster | Non-imaging Biomarkers |
Validating the Clinical Usefulness of the Timed 25-Foot Walk in MS in Routine Clinical Practice |
Sage T Hewitt, B.S.1, Derrick Robertson, MD2, Angela Aungst, MPH3 and Christopher James, B.S.1, (1)USF Health Morsani College of Medicine, Tampa, FL, (2)College of Medicine, Neurology, University of South Florida, Tampa, FL, (3)Multiple Sclerosis Division Department of Neurology University of South Florida, Florida, FL |
| 2021 | NIB07 | Poster | Non-imaging Biomarkers |
Cerebrospinal Fluid Protein Is Higher in Males with Multiple Sclerosis: Results from an International Multicenter Cohort |
Sam I Hooshmand, DO1, Khalid El-Salem, MD2, Suha Agaileh, MD2 and Ahmed Z Obeidat, MD, PhD1, (1)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurosciences, Jordan University of Science and Technology, Irbid, Jordan |
| 2021 | NNN01 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Identifying Prospective Memory Deficits in MS with a Single Task from the Memory for Intentions Test: An IRT and ROC Analysis |
Elizabeth S Gromisch, PhD1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7 and Sarah A Raskin, PhD8,9, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT |
| 2021 | NNN02 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Stability of the Gut Microbiota in Persons with Pediatric-Onset Multiple Sclerosis and Related Demyelinating Diseases |
| 2021 | NNN03 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Evaluation of Apathy in Multiple Sclerosis |
Jeannie Lengenfelder, PhD1, Helen Genova, PhD1, Jacqueline Leddy, BA1, Brea Rivera, BS2 and Nancy D Chiaravalloti, PhD1, (1)Kessler Foundation, East Hanover, NJ, (2)Montclair State University, Montclair, NJ |
| 2021 | NNN04 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
FlywheelMS: Stratification of Anxiety and Depression By MS Subtype As Captured in Digitized Health Records |
Kelly Zalocusky, PhD1, Ryan Gan, PhD, MPH1, Shemra Rizzo, PhD1, Katherine Belendiuk, PhD1, Laura Gaetano, PhD2, Jumaah Goldberg, DPT1, Nicole Bonine, PhD, MPH1, Gillian Hanson, ND3, Kieran Mace, PhD3 and Yifeng Jenny Chia, PhD1, (1)Genentech, Inc., South San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)PicnicHealth, San Francisco, CA |
| 2021 | NNN05 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Validation of Paced Auditory Serial Addition Test (PASAT) Regression Normative Data for Performance and Cognitive Fatigability in Multiple Sclerosis |
Caitlin S Walker, H.BA., Carleton University, Ottawa, ON, Canada, Jason A Berard, PhD, Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada and Lisa A.S. Walker, Ph.D., The Ottawa Hospital Research Institute, Ottawa, ON, Canada |
| 2021 | NNN06 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Synesthesia May be Prevalent in Multiple Sclerosis |
Melissa Villafana, B.A.1, Glenn R Wylie, Ph.D.2 and Ruth E Propper, Ph.D.1, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ |
| 2021 | NNN07 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Examining the Influence of Processing Speed on the Relation between Backward Walking and Falls in Persons with Multiple Sclerosis |
Erin M Edwards, B.S.1, Ana M Daugherty, PhD2 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Psychology, Wayne State University, Detroit, MI |
| 2021 | NNN08 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Longitudinal Olfactory Patterns in Multiple Sclerosis: A Scoping Review and Implications for Use in Management of Disease |
Lauren L Frederick, BS1, Ram Sivakumar, BS1, Sharon G Lynch, MD2 and Jennifer Villwock, MD3, (1)University of Kansas Medical Center, Kansas City, KS, (2)Neurology, University of Kansas Medical Center, Kansas City, KS, (3)Otolaryngology, University of Kansas Medical Center, Kansas City, KS |
| 2021 | NNN09 | Poster | Neurophysiology; Neuropsychology and Neuropsychiatry |
Negative Dual Task Effects Can be Similar in People with Multiple Sclerosis and Controls, but Depend on Processing Time, Not Single Task Performance |
Sheri L Bunyan, PhD, PT1,2 and Alexander V Ng, PhD2, (1)Physical Therapy, University of Wisconsin – Stevens Point, Stevens Point, WI, (2)Exercise Science, Marquette University, Milwaukee, WI |
| 2021 | NPP01 | Poster | Neuropathology and Pathogenesis |
Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico |
| 2021 | NPP02 | Poster | Neuropathology and Pathogenesis |
Altered Expression of the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 (A1) Contributes to the Pathogenesis of Neurodegeneration in Multiple Sclerosis |
Amber Anees, BSc., Health Sciences, University of Saskatchewan, Saskatoon, SK, Canada, Michael Levin, FRCPC, Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, Hannah E Salapa, PhD, Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada and Patricia Thibault, PhD, University of Saskatchewan, Saskatoon, SK, Canada |
| 2021 | PGM01 | Poster | Programs |
The Influence of Tethered and Joint HCP and Patient Education on Clinical Practice Behavior, Patient Activation, and Empowerment |
Carole Drexel, PhD1, Elizabeth L. del Nido, BA1, Scott D. Newsome, DO, MSCS, FAAN, FANA2, June Halper, MSN, APN-C, MSCN, FAAN3 and Wendy Turell, DrPH1, (1)PlatformQ Health Education, Needham, MA, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Consortium of Multiple Sclerosis Centers, Hackensack, NJ |
| 2021 | PGM02 | Poster | Programs |
Impact of a Virtual Wellness Program on Quality-of-Life Measures for Patients Living with MS during the COVID-19 Pandemic |
Dina Jacobs, MD1, Nora Garland, MSW, LSW1, Vanessa Zimmerman, MSN, RN, MSCN1 and Sarah M Weinstein, MS2, (1)Neurology, University of Pennsylvania, Philadelphia, PA, (2)Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA |
| 2021 | PGM03 | Poster | Programs |
National MS Society Black MS Experience Summit, a Culturally Responsive Virtual Education Program for People Affected By MS |
Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Hooper K, Marshall J, Stewart K |
| 2021 | PGM04 | Poster | Programs |
National MS Society Ask an MS Expert Offers Virtual Education Programing for People Affected By MS |
Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Fiol J, Szafran E, Barnola A, Costello K |
| 2021 | PGM05 | Poster | Programs |
National MS Society Facebook Community Offers Connection and Virtual Education Options for People Affected By MS |
Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Herrmann B, Anzada P, Benson T, Gasper-Krueger A, Baker C, Cohrs R, Jensen A, Roper E, Ovsepian N |
| 2021 | PGM06 | Poster | Programs |
Knowledge, Skills, and Confidence of Healthcare Professionals Participating in the Echo MS Program |
Kevin N Alschuler, PhD1,2, Darren Ball, M.Ed.3, Annette Wundes, MD4, Salim Chahin, MD5, Mark Skeen, MD6 and Gloria von Geldern, MD4, (1)Department of Neurology, University of Washington School of Medicine, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)National Multiple Sclerosis Society, New York, NY, (4)Neurology, University of Washington, Seattle, WA, (5)Washington University in St. Louis, St. Louis, MO, (6)Neurology, Duke University, Durham, NC |
| 2021 | PGM07 | Poster | Programs |
Improving MS Care through Educational Outreach to Generalists |
Lynda R Hillman, DNP, MS Center of Excellence, West, VA Puget Sound Healthcare, Seattle, WA and Nancy Harris, MN, RN, VA-ECHO, VA Puget Sound Healthcare System, Seattle, WA |